ALLIQUA BIOMEDICAL INC - COM NEW (ALQA)

CUSIP: 019621200

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM NEW
Total 13F shares
4,372,233
Share change
+1,364,958
Total reported value
$23,170,235
Price per share
$5.30
Number of holders
21
Value change
+$7,277,456
Number of buys
14
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 019621200?
CUSIP 019621200 identifies ALQA - ALLIQUA BIOMEDICAL INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ALLIQUA BIOMEDICAL INC - COM NEW (ALQA) as of Q4 2014

As of 31 Dec 2014, ALLIQUA BIOMEDICAL INC - COM NEW (ALQA) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,372,233 shares. The largest 10 holders included J. Goldman & Co LP, Broadfin Capital, LLC, PERCEPTIVE ADVISORS LLC, SUFFOLK CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Leonard Capital Management INC, THOMSON HORSTMANN & BRYANT INC, GEODE CAPITAL MANAGEMENT, LLC, WELCH & FORBES LLC, and HighTower Advisors, LLC. This page lists 21 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.